Predicate |
Object |
assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_00cfef8c93ad4379919a12bee6a2333e |
classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P35-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-497 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D491-107 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D407-14 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-444 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D401-14 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D401-04 |
classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D401-04 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D401-14 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D407-14 |
filingDate |
2020-04-10-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
grantDate |
2023-07-18-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_0d38ca1b7125e5a868fab71d1bfa1de2 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_4d043b6c3bcfa40a30c7c5dffd7b988d http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_8ea1a37749dd2de9accc87c44ba76d52 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_42162153c690d4ec7f71305936144a71 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_6fd82f57630b87fdabaf521a9cf7f458 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_fe3e877fe9189207c0b568aee2c4737b http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_fbbc5e4177c081a7383124e2cbf9cd92 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_db061e15fb6d94e0407b198c7344b499 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_ea91392a441e57745a0651ccd79c52b7 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_5f45669240c94f507aa19e3370fb4213 |
publicationDate |
2023-07-18-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber |
US-11702411-B2 |
titleOfInvention |
Pyridine, pyrazine, and triazine compounds as allosteric SHP2 inhibitors |
abstract |
The present disclosure is directed to inhibitors of SHP2 and their use in the treatment of disease. Also disclosed are pharmaceutical compositions comprising the same. |
priorityDate |
2017-10-12-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
type |
http://data.epo.org/linked-data/def/patent/Publication |